| Ytd | -3.43% | |
| 1y | -1.51% |
| Open | 36.51 | Prev Close | 36.84 | Low | 36.12 | High | 36.96 | Mkt Cap | 2.13B |
| Vol | 143.27K | Avg Vol | 848.97K | EPS | 2.48 | P/E | 14.85 | Forward P/E | 11.04 |
| Beta | 0.94 | Short Ratio | 5.83 | Inst. Own | 103.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 33.48 | 200-d Avg | 32.69 | 1yr Est | 44.91 |
Harmony Biosciences (HRMY) was a big mover last session on higher-than-average trading volume. The l
PLYMOUTH MEETING, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq:
Harmony Biosciences posts preliminary Q2 2026 Wakix revenues of about $261M, up 30% year over year,
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Harmony Biosciences Hldgs (NASDAQ:
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary, unaudited second quart
Harmony Biosciences Hldgs (NASDAQ:HRMY) affirms prelim FY2026 sales outlook from $1.000 billion-$1.0
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today anno
The mean of analysts' price targets for Harmony Biosciences (HRMY) points to a 27.4% upside in the s
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Bi
Five low price-to-book stocks pass our value screens with low P/B, P/S and PEG metrics, highlighting
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
MEOH, LTM and HRMY made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 14th, 2026.
Deutsche Bank analyst David Hoang maintains Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Hold a
Harmony Biosciences trades at discounted valuations, but investors are weighing Wakix dependence, re
Harmony Biosciences is leveraging Wakix growth to expand its neuroscience pipeline, while advancing
Harmony Biosciences is broadening beyond Wakix with pitolisant programs, orexin research and rare ep
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today ann
Harmony Biosciences Holdings, Inc. (HRMY) Presents at Goldman Sachs 47th Annual Global Healthcare Co
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team wi
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today ann
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.55 per share, missi
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today repo
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Gainers
U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Tuesday. Here are some big
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f